vs
ADAMAS TRUST, INC.（ADAM）与Amarin Corp plc（AMRN）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是ADAMAS TRUST, INC.的1.0倍（$45.1M vs $43.2M），ADAMAS TRUST, INC.净利率更高（124.0% vs -23.3%，领先147.3%），ADAMAS TRUST, INC.同比增速更快（61.6% vs 7.0%），过去两年ADAMAS TRUST, INC.的营收复合增速更高（55.5% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
ADAM vs AMRN — 直观对比
营收规模更大
AMRN
是对方的1.0倍
$43.2M
营收增速更快
ADAM
高出54.6%
7.0%
净利率更高
ADAM
高出147.3%
-23.3%
两年增速更快
ADAM
近两年复合增速
-18.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $43.2M | $45.1M |
| 净利润 | $53.5M | $-10.5M |
| 毛利率 | — | — |
| 营业利润率 | — | 35.5% |
| 净利率 | 124.0% | -23.3% |
| 营收同比 | 61.6% | 7.0% |
| 净利润同比 | 270.5% | 33.0% |
| 每股收益（稀释后） | $0.45 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADAMAMRN
| Q1 26 | — | $45.1M | ||
| Q4 25 | $43.2M | $49.2M | ||
| Q3 25 | $36.6M | $49.7M | ||
| Q2 25 | $36.4M | $72.7M | ||
| Q1 25 | $33.1M | $42.0M | ||
| Q4 24 | $26.7M | $62.3M | ||
| Q3 24 | $20.2M | $42.3M | ||
| Q2 24 | $19.0M | $67.5M |
净利润ADAMAMRN
| Q1 26 | — | $-10.5M | ||
| Q4 25 | $53.5M | $-1.2M | ||
| Q3 25 | $44.8M | $-7.7M | ||
| Q2 25 | $8.5M | $-14.1M | ||
| Q1 25 | $42.2M | $-15.7M | ||
| Q4 24 | $-31.4M | $-48.6M | ||
| Q3 24 | $42.8M | $-25.1M | ||
| Q2 24 | $-15.6M | $1.5M |
毛利率ADAMAMRN
| Q1 26 | — | — | ||
| Q4 25 | — | 47.1% | ||
| Q3 25 | — | 44.7% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 59.8% | ||
| Q4 24 | — | -15.4% | ||
| Q3 24 | — | 38.5% | ||
| Q2 24 | — | 63.4% |
营业利润率ADAMAMRN
| Q1 26 | — | 35.5% | ||
| Q4 25 | — | -12.9% | ||
| Q3 25 | — | -22.4% | ||
| Q2 25 | 11.7% | -22.0% | ||
| Q1 25 | — | -39.9% | ||
| Q4 24 | -119.0% | -84.3% | ||
| Q3 24 | — | -59.5% | ||
| Q2 24 | -124.7% | -0.8% |
净利率ADAMAMRN
| Q1 26 | — | -23.3% | ||
| Q4 25 | 124.0% | -2.5% | ||
| Q3 25 | 122.5% | -15.6% | ||
| Q2 25 | 23.4% | -19.4% | ||
| Q1 25 | 127.4% | -37.4% | ||
| Q4 24 | -117.5% | -78.0% | ||
| Q3 24 | 211.7% | -59.4% | ||
| Q2 24 | -81.9% | 2.3% |
每股收益（稀释后）ADAMAMRN
| Q1 26 | — | — | ||
| Q4 25 | $0.45 | $0.00 | ||
| Q3 25 | $0.36 | $-0.02 | ||
| Q2 25 | $-0.04 | $-0.03 | ||
| Q1 25 | $0.33 | $-0.04 | ||
| Q4 24 | $-0.46 | $-0.12 | ||
| Q3 24 | $0.36 | $-0.06 | ||
| Q2 24 | $-0.29 | $0.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $210.3M | $307.8M |
| 总债务越低越好 | $735.8M | — |
| 股东权益账面价值 | $1.4B | — |
| 总资产 | $12.6B | $645.8M |
| 负债/权益比越低杠杆越低 | 0.52× | — |
8季度趋势，按日历期对齐
现金及短期投资ADAMAMRN
| Q1 26 | — | $307.8M | ||
| Q4 25 | $210.3M | $302.6M | ||
| Q3 25 | $185.3M | $286.6M | ||
| Q2 25 | $160.4M | $298.7M | ||
| Q1 25 | $177.1M | $281.8M | ||
| Q4 24 | $167.4M | $294.2M | ||
| Q3 24 | $195.1M | $305.7M | ||
| Q2 24 | $235.5M | $306.7M |
总债务ADAMAMRN
| Q1 26 | — | — | ||
| Q4 25 | $735.8M | — | ||
| Q3 25 | $766.6M | — | ||
| Q2 25 | $653.0M | — | ||
| Q1 25 | $654.4M | — | ||
| Q4 24 | $573.2M | — | ||
| Q3 24 | $699.4M | — | ||
| Q2 24 | $800.7M | — |
股东权益ADAMAMRN
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | $459.3M | ||
| Q3 25 | $1.4B | $458.9M | ||
| Q2 25 | $1.4B | $464.9M | ||
| Q1 25 | $1.4B | $473.7M | ||
| Q4 24 | $1.4B | $486.2M | ||
| Q3 24 | $1.4B | $531.4M | ||
| Q2 24 | $1.4B | $551.9M |
总资产ADAMAMRN
| Q1 26 | — | $645.8M | ||
| Q4 25 | $12.6B | $670.8M | ||
| Q3 25 | $12.4B | $659.8M | ||
| Q2 25 | $10.6B | $670.1M | ||
| Q1 25 | $10.0B | $655.7M | ||
| Q4 24 | $9.2B | $685.3M | ||
| Q3 24 | $8.9B | $750.6M | ||
| Q2 24 | $8.2B | $799.9M |
负债/权益比ADAMAMRN
| Q1 26 | — | — | ||
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.56× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $134.0M | — |
| 自由现金流经营现金流 - 资本支出 | $125.9M | — |
| 自由现金流率自由现金流/营收 | 291.6% | — |
| 资本支出强度资本支出/营收 | 18.9% | — |
| 现金转化率经营现金流/净利润 | 2.50× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ADAMAMRN
| Q1 26 | — | — | ||
| Q4 25 | $134.0M | $15.3M | ||
| Q3 25 | $6.9M | $-12.7M | ||
| Q2 25 | $39.2M | $16.6M | ||
| Q1 25 | $25.8M | $-12.5M | ||
| Q4 24 | $14.1M | $-13.3M | ||
| Q3 24 | $-922.0K | $-2.4M | ||
| Q2 24 | $-993.0K | $-2.7M |
自由现金流ADAMAMRN
| Q1 26 | — | — | ||
| Q4 25 | $125.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-10.6M | — | ||
| Q3 24 | $-8.6M | — | ||
| Q2 24 | $-8.6M | — |
自由现金流率ADAMAMRN
| Q1 26 | — | — | ||
| Q4 25 | 291.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -39.6% | — | ||
| Q3 24 | -42.3% | — | ||
| Q2 24 | -44.9% | — |
资本支出强度ADAMAMRN
| Q1 26 | — | — | ||
| Q4 25 | 18.9% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 92.3% | — | ||
| Q3 24 | 37.7% | — | ||
| Q2 24 | 39.7% | — |
现金转化率ADAMAMRN
| Q1 26 | — | — | ||
| Q4 25 | 2.50× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 4.59× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.02× | — | ||
| Q2 24 | — | -1.81× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADAM
| Other | $19.6M | 45% |
| Constructive Loans LLC | $14.4M | 33% |
| Multifamily | $9.1M | 21% |
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
